ARYD vs. FHLT, PRE, RVPH, ACRS, ASRT, YI, VTVT, CMRX, ONCY, and GNLX
Should you be buying ARYA Sciences Acquisition Corp IV stock or one of its competitors? The main competitors of ARYA Sciences Acquisition Corp IV include Future Health ESG (FHLT), Prenetics Global (PRE), Reviva Pharmaceuticals (RVPH), Aclaris Therapeutics (ACRS), Assertio (ASRT), 111 (YI), vTv Therapeutics (VTVT), Chimerix (CMRX), Oncolytics Biotech (ONCY), and Genelux (GNLX). These companies are all part of the "medical" sector.
ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) and Future Health ESG (NASDAQ:FHLT) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, community ranking, valuation and risk.
In the previous week, ARYA Sciences Acquisition Corp IV's average media sentiment score of 0.00 equaled Future Health ESG'saverage media sentiment score.
ARYA Sciences Acquisition Corp IV has a beta of -0.01, meaning that its stock price is 101% less volatile than the S&P 500. Comparatively, Future Health ESG has a beta of -0.12, meaning that its stock price is 112% less volatile than the S&P 500.
ARYA Sciences Acquisition Corp IV and Future Health ESG both received 0 outperform votes by MarketBeat users.
Future Health ESG's return on equity of -9.79% beat ARYA Sciences Acquisition Corp IV's return on equity.
48.1% of ARYA Sciences Acquisition Corp IV shares are held by institutional investors. Comparatively, 24.6% of Future Health ESG shares are held by institutional investors. 53.5% of ARYA Sciences Acquisition Corp IV shares are held by insiders. Comparatively, 57.2% of Future Health ESG shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
Future Health ESG beats ARYA Sciences Acquisition Corp IV on 4 of the 6 factors compared between the two stocks.
Get ARYA Sciences Acquisition Corp IV News Delivered to You Automatically
Sign up to receive the latest news and ratings for ARYD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ARYD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ARYA Sciences Acquisition Corp IV Competitors List
Related Companies and Tools
